February 24-27, 2020 London, UK - CAR-TCR Summit Europe

News & Events

Stay update

February 24-27, 2020 London, UK - CAR-TCR Summit Europe ▾

February 24-27, 2020 London, UK - CAR-TCR Summit Europe

The CAR-TCR Summit Europe will be held from February 24 to 27, 2020 in London, United Kingdom.

Dr. Luca Alberici, MolMed's Chief Business Officer, will present MolMed activity discussing about development, clinical and commercial GMP supply of next generation Vectors and cell therapies on February 25 at 8:30 AM GMT.

Follow the event at the link https://cartcr-europe.com/

Subscribe to press releases

Contacts

Investor Relations & Communication Manager
Phone: +39 02 21277.205
E-mail: investor.relations@molmed.com

Investors

Contacts

Investor Relations & Communication Department
Telefono: +39 02 21277.321
E-mail: investor.relations@molmed.com

Investors

Dear Users, we would like to inform you that, as of 30 September, AGC Biologics S.p.A. (formerly MolMed S.p.A.) is no longer listed on the Milan Stock Exchange and has become part of the AGC Biologics Group. For any information on the company and the group, you are kindly invited to consult the websitewww.agcbio.com.
The contents present on this portal (www.molmed.com) are updated until the date of September 30, 2020 and will be available for the time frame foreseen by applicable regulations.
In addition, the "work with us" section is still active, while the contact details are no longer accessible.

News & Events

Stay update

February 24-27, 2020 London, UK - CAR-TCR Summit Europe ▾